Kelvin A. Moses

Vanderbilt University Medical Center — United States

Medicine · Health Sciences

34h-index5.0kcitations198works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(41), Prostate Cancer Diagnosis and Treatment(36), Bladder and Urothelial Cancer Treatments(28), Global Cancer Incidence and Screening(20), Urinary and Genital Oncology Studies(16)

Publications198 total

Global Examination of Health Literacy in Urologic Malignancies
Urology·2026
USING RE-AIM TO IDENTIFY IMPLEMENTATION DETERMINANTS OF CARDIOVASCULAR RISK STRATIFICATION SCORE FOR PATIENTS WITH PROSTATE CANCER
2025Open Access
Association of Patient Health Literacy With NCCN-Concordant Colorectal Cancer Treatment and Survival
Journal of the National Comprehensive Cancer Network·2025
Penile Cancer Survivorship: Research Gaps in Psychosocial Health and Sexual Quality of Life
European Urology Oncology·2025
Identifying Risk of Progression Among Patients With Biochemical Recurrence Remains a Challenge
The Journal of Urology·2025
Barriers to Breast Cancer Care for Women Presenting at District and Regional-Level Hospitals in Ghana: Findings From the African Breast Cancer-Disparities in Outcomes Ghana Study
JCO Global Oncology·2025Open Access
Long-term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience
Journal of Kidney Cancer and VHL·2025Open Access
The Geographic Mismatch Between Urologic Services and Urologists in the United States
Urology Practice·2025· 1 cited
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: Erratum
The Journal of Urology·2025· 2 cited
IP04-35 QUANTIFYING LOCUMS UROLOGY: A QUARTER OF COUNTIES WITH UROLOGIC SERVICES LACK A UROLOGIST
The Journal of Urology·2025
MP02-01 THE EFFECT OF ALLOGENIC BLOOD TRANSFUSION ON ONCOLOGIC OUTCOMES IN LOCALLY ADVANCED KIDNEY CANCER
The Journal of Urology·2025
IP04-20 COMPARING FUNCTIONAL OUTCOMES AFTER LOCALIZED PROSTATE CANCER TREATMENT BETWEEN BLACK AND WHITE MEN
The Journal of Urology·2025
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitors
The Oncologist·2025· 1 citedOpen Access
Health literacy and all‐cause mortality among cancer patients
Cancer·2025· 13 citedOpen Access
ASSOCIATION OF PRIOR ABDOMINAL SURGERY WITH PERI- AND POST-OPERATIVE OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
Urologic Oncology Seminars and Original Investigations·2025
Extensive necrosis as a prognostic indicator in metastatic RCC patients undergoing deferred cytoreductive nephrectomy after immunologic checkpoint inhibitor treatment.
Journal of Clinical Oncology·2025· 1 cited
Cognitive effects of androgen receptor (AR) directed therapies for advanced cancer of the prostate (COGCaP): A comparison of enzalutamide vs abiraterone acetate.
Journal of Clinical Oncology·2025· 1 cited
Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel‐T
Prostate Cancer·2025Open Access
Long-term Safety and Efficacy of Belzutifan in Von Hippel-Lindau Syndrome: A VHL Coordinating Care Center Experience.
PubMed·2025Open Access
North American study and meta-analysis evaluating performance of Bladder EpiCheck<sup>®</sup>, a FDA cleared test, in non-muscle invasive bladder cancer recurrence
Bladder Cancer·2024· 3 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Robert J. Schwartz(8), Daniel A. Barocas(6), David F. Penson(6), Zachary Klaassen(6), Martha K. Terris(5), Ruth Etzioni(4), Matthew J. Resnick(4), Christopher J.D. Wallis(4), Jonathan I. Epstein(3), Geoffrey A. Sonn(3), Preston Sprenkle(3), Sigrid Carlsson(3), Scott E. Eggener(3), Simpa S. Salami(3), Warren E. Zimmer(3), Viraj A. Master(3), Kristen R. Scarpato(3), Joseph A. Smith(3), Peter E. Clark(3), Wayland Hsiao(3)